| 07:00 | GSK | Transaction in Own Shares | RNS |
| 01.08.2025 15:00 | GSK | Total Voting Rights | RNS |
| 01.08.2025 09:40 | POLR, RWA, LIO | LONDON BROKER RATINGS: Taylor Wimpey, Pets At Home, Just Group are cut | Alliance |
| 01.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 31.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 30.07.2025 09:01 | GSK | GSK eyes top-end annual results as second quarter beats expectations | Alliance |
| 30.07.2025 07:05 | GSK | Transaction in Own Shares | RNS |
| 30.07.2025 07:00 | GSK | 2nd Quarter Results | RNS |
| 29.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 28.07.2025 08:22 | GSK | GSK strikes USD12 billion drug portfolio deal with Hengrui Pharma | Alliance |
| 28.07.2025 07:00 | GSK | GSK enters Hengrui Pharma collaboration agreements | RNS |
| 28.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 25.07.2025 08:18 | GSK | GSK hails EU approval for blood cancer drug as US regulator wavers | Alliance |
| 25.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 24.07.2025 17:00 | GSK | Blenrep approved in the EU for multiple myeloma | RNS |
| 24.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 23.07.2025 19:52 | GSK | GSK says US FDA extends review period for Blenrep BLA until October | Alliance |
| 23.07.2025 17:00 | GSK | US FDA review extended for Blenrep | RNS |
| 23.07.2025 14:01 | SEPL, SWR, SGE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 22.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 21.07.2025 09:33 | BHP, VAL, VALT | LONDON BROKER RATINGS: Stifel cuts Weir Group; BofA raises Pennon | Alliance |
| 21.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 18.07.2025 07:01 | GSK | Setback for GSK as Blenrep does not win US FDA committee support | Alliance |
| 18.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.07.2025 07:00 | GSK | Blenrep US ODAC outcome | RNS |
| 17.07.2025 09:56 | GSK | GSK wins US approval for prefilled syringe version of shingles vaccine | Alliance |
| 17.07.2025 07:00 | GSK | GSK’s Shingrix Fully Liquid FDA approval | RNS |
| 17.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 16.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 15.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 14.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 14.07.2025 08:21 | GSK | GSK seeks FDA green light for expanded use of RSV vaccine Arexvy | Alliance |
| 14.07.2025 07:00 | GSK | GSK submits Arexvy for adults 18-49 AIR to FDA | RNS |
| 14.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 11.07.2025 09:45 | GSK, NWG, LMP | LONDON BROKER RATINGS: Jet2 raised to 'buy'; Investec cuts Pagegroup | Alliance |
| 11.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 10.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 09.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 08.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 07.07.2025 16:00 | GSK | GSK completes acquisition of efimosfermin for SLD | RNS |
| 07.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 04.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 03.07.2025 16:44 | VTA, POLR, KITW | UK dividends calendar - next 7 days | Alliance |
| 03.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 02.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 01.07.2025 15:00 | GSK | Total Voting Rights | RNS |
| 01.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 30.06.2025 09:38 | TLW, KOS, ZEG | LONDON BROKER RATINGS: Babcock International price targets raised | Alliance |
| 30.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 27.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 26.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 25.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 24.06.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 24.06.2025 15:00 | GSK | Director Declaration | RNS |
| 24.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 23.06.2025 17:50 | GSK | Replacement - Director/PDMR Shareholding | RNS |
| 23.06.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.06.2025 09:55 | GSK | GSK drug to treat itch caused by liver disease accepted for EU review | Alliance |
| 23.06.2025 08:30 | GSK | Replacement RNS: Linerixibat file accepted by EMA | RNS |
| 23.06.2025 08:18 | GSK | GSK Submits Arexvy for adults 18+ with EMA | RNS |
| 23.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 20.06.2025 08:27 | GSK | Japan accepts GSK application for expanded use of RSV vaccine Arexvy | Alliance |
| 20.06.2025 07:00 | GSK | Arexvy filed in Japan for 18-49 at increased risk | RNS |
| 20.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 19.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 17.06.2025 12:36 | BME, 1SN, GSK | DIRECTOR DEALINGS: New B&M CEO Tjeerd Jegen buys GBP500,000 in shares | Alliance |
| 17.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 16.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 13.06.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 13.06.2025 08:14 | GSK | GSK's RSV drug Arexvy accepted for regulatory review in Europe | Alliance |
| 13.06.2025 07:00 | GSK | Transaction in Own Shares | RNS |
